Dr. Paul R. Carney

Pediatric Neurology
1020 Hitt St, 
Columbia, MO 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
1020 Hitt St, 
Columbia, MO 
OverviewInsuranceLocationsClinical Research

Overview

Paul Carney is a Pediatric Neurologist in Columbia, Missouri. Dr. Carney is rated as an Experienced provider by MediFind in the treatment of Bell's Palsy. His top areas of expertise are Seizures, Epilepsy, Myoclonic Epilepsy, Angelman Syndrome, and Thrombectomy. Dr. Carney is currently accepting new patients.

His clinical research consists of co-authoring 65 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Neurology
Licenses
Neurology with Special Qualifications in Neurology in FL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1020 Hitt St, Columbia, MO 65212

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
A Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures
Enrollment Status: Recruiting
Publish Date: September 10, 2025
Intervention Type: Drug
Study Drug: Xcopri
Study Phase: Phase 1
An Open-Label, Single-Dose, Pharmacokinetics Study of VALTOCO® With Open-Label Safety Period in Pediatric Subjects With Epilepsy
An Open-Label, Single-Dose, Pharmacokinetics Study of VALTOCO® With Open-Label Safety Period in Pediatric Subjects With Epilepsy
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Drug
Study Drug: Diazepam Nasal Spray [Valtoco]
Study Phase: Phase 1/Phase 2
Physician Expanded Access to Investigational New Drug Cannabidiol for the Treatment of Drug Resistant Epilepsy
Physician Expanded Access to Investigational New Drug Cannabidiol for the Treatment of Drug Resistant Epilepsy
Enrollment Status: No_longer_available
Publish Date: January 22, 2019
Intervention Type: Other, Drug
View 2 Less Clinical Trial

65 Total Publications

Precision Genomics: A Reality Having Universal Impact in a New Era of Psychiatry - Lessons Learned, Past and Present.
Precision Genomics: A Reality Having Universal Impact in a New Era of Psychiatry - Lessons Learned, Past and Present.
Journal: Journal of addiction psychiatry
Published: September 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Carney's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile